ArticleTherapeutic advances in drug safety2026

Adverse events associated with statin co-use in breast cancer patients: a disproportionality analysis based on the FDA Adverse Event Reporting System.

Yunnan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.